14.26 0.46 (3.33%)
4:00 PM ET 11/30/09
Company Profile
Price and Volume
Recent Price 13.80
52 Week High 15.69
52 Week Low 5.92
Avg. Daily Vol. (Mil) 2.86
Beta (3 year) 1.73
Share Related Items
Mkt Cap (Mil) 1,956.05
Shares Out (Mil) 141.74
Float (Mil) 138.02
Dividend Information
Yield % 0.00
Annual Dividend 0.00
Payout Ratio 0.00
Financial Strength
Quick Ratio 2.50
Current Ratio 3.10
LT Debt/ Equity 1.53
Total Debt / Equity 1.60
Valuation Ratios
Price Earnings n.a.
Price/Sales 2.39
Price/Book 4.23
Price/Cash Flow -9.90
Per Share Data
Earnings -1.73
Sales 5.76
Book Value 3.26
Cash Flow -1.40
Business Summary
A biopharmaceutical company, which is engaged in the discovery, development and commercialization of innovative medicines for the treatment of diabetes, obesity and other diseases.
General Information
9360 Towne Centre Drive
San Diego, CA 92121
www.amylin.com
Industry : Drugs
Sector: Health Care
Employees: 1800
CEO: Daniel M. Bradbury
Short Interest
Current Month (Mil) 8.54
Previous Month (Mil) 10.20
Short Interest Ratio (Days) 3.10
Management Effectiveness
Return on Equity n.a.
Return on Assets -14.40
Return on Investments -20.00
Profitability
Gross Margin 94.50
EBIT Margin -26.40
Profit Margin -29.40
Dow Jones S&P 500 NASDAQ 10-Year Note
10,344.84 1,095.63 2,144.60 32.01
Oil *
78.55
UP
34.92
UP
4.14
UP
6.16
DOWN
0.30
10 Yr
3.20%
SPDR Gold
115.65
+0.34%
+0.38%
+0.29%
-0.93%
Data delayed 20 minutes

Brokerage Partners

TheStreet Premium Services

All Services